Abstract
Pleomorphic carcinoma (PC) is a rare and highly aggressive subtype of non-small cell lung cancer. We report a case of a 66-year-old male whose tumor demonstrated explosive growth, expanding from 2 cm to 7 cm in just 2.5 months. Despite the rapid progression and subsequent development of brain metastasis, aggressive surgical intervention for both the primary and secondary lesions resulted in successful local control and social reintegration. This case suggests that surgical resection can be a beneficial therapeutic strategy for PC, even in the face of rapid progression.
Introduction
Pleomorphic carcinoma is a rare pulmonary malignancy, accounting for approximately 0.3% of all lung tumors. It is defined pathologically by the presence of at least 10% spindle and/or giant cells in a non-small cell lung cancer framework. PC is notorious for its high-grade malignancy, rapid growth velocity, and poor response to conventional chemotherapy. This case highlights the clinical challenges of managing such an aggressive tumor and the potential role of surgery in improving patient outcomes.
Case Presentation
A 66-year-old male was undergoing follow-up after gastric cancer surgery when a 2 cm nodule was detected in the right upper lobe via chest CT. Over the next 10 weeks, the tumor demonstrated remarkable velocity, expanding to 7 cm in diameter.
Initial diagnostic efforts, including transbronchial lung biopsy, were inconclusive, a common issue with the heterogeneous nature of PC. Staging investigations included bone scintigraphy, which revealed abnormal uptake in the left distal femur, initially raising concerns about distant metastasis.
However, further investigations did not confirm metastatic disease in the bone. Given the urgent need for local control of the rapidly expanding lung mass, a right upper lobectomy with lymph node dissection (ND2a) was performed. Pathological examination of the resected specimen confirmed the diagnosis of pleomorphic carcinoma, showing a complex architecture of large cell carcinoma, spindle cells, and giant cells.
Five months post-surgery, the patient developed brain metastasis. While initial radiation therapy (Gamma Knife) provided only temporary relief, surgical resection of the brain lesion eight months later successfully alleviated neurological symptoms and provided durable local control.
Discussion
The "explosive" growth rate observed in this case—a 3.5-fold increase in diameter over 10 weeks—underscores the aggressive nature of PC. Such rapid progression necessitates a shortened interval between detection and surgical intervention to prevent the tumor from becoming unresectable.
Pre-operative diagnosis remains a significant challenge; standard biopsies often fail to capture the spindle or giant cell components required for a PC diagnosis. In this instance, a definitive diagnosis was only possible post-resection. Furthermore, this case suggests that aggressive surgery can play a vital role in managing PC. While often considered a systemic disease early on, surgical resection of both primary and metastatic lesions provided effective local control and palliative benefits that radiation alone could not achieve.
Conclusion
Pleomorphic carcinoma presents a high-grade clinical challenge where surgical indications must be carefully weighed. However, this case demonstrates that aggressive resection of both the primary tumor and subsequent metastases can be a viable and effective means of achieving local control and improving quality of life. At 20 months post-operation, the patient remains alive and has successfully returned to his social life, significantly exceeding the median survival rates typically associated with this malignancy.
Summary updated